Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.025 EUR
−369.00 K EUR
32.25 M EUR
5.56 M
About BIOFRONTERA AG
Sector
Headquarters
Leverkusen
Founded
1997
Website
ISIN
DE000A4BGGM7
FIGI
BBG000BV2BQ3
Biofrontera AG engages in the research, development, and marketing of dermatological products. Its products include Ameluz, BF-RhodolesXepi and Belixos. The company was founded by Hermann Lübbert in 1997 and is headquartered in Leverkusen, Germany.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of B8FK is 2.150 EUR — it has decreased by −0.70% in the past 24 hours. Watch BIOFRONTERA AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on XETR exchange BIOFRONTERA AG stocks are traded under the ticker B8FK.
B8FK stock has fallen by −0.47% compared to the previous week, the month change is a −16.41% fall, over the last year BIOFRONTERA AG has showed a −40.28% decrease.
B8FK reached its all-time high on May 15, 2024 with the price of 4.380 EUR, and its all-time low was 2.085 EUR and was reached on Dec 27, 2024. View more price dynamics on B8FK chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
B8FK stock is 5.77% volatile and has beta coefficient of −0.13. Track BIOFRONTERA AG stock price on the chart and check out the list of the most volatile stocks — is BIOFRONTERA AG there?
Today BIOFRONTERA AG has the market capitalization of 13.10 M, it has increased by 1.10% over the last week.
Yes, you can track BIOFRONTERA AG financials in yearly and quarterly reports right on TradingView.
BIOFRONTERA AG is going to release the next earnings report on Apr 24, 2025. Keep track of upcoming events with our Earnings Calendar.
B8FK net income for the last quarter is −931.00 K EUR, while the quarter before that showed −2.64 M EUR of net income which accounts for 64.68% change. Track more BIOFRONTERA AG financial stats to get the full picture.
No, B8FK doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 95.00 employees. See our rating of the largest employees — is BIOFRONTERA AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOFRONTERA AG EBITDA is −4.00 M EUR, and current EBITDA margin is 17.28%. See more stats in BIOFRONTERA AG financial statements.
Like other stocks, B8FK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOFRONTERA AG stock right from TradingView charts — choose your broker and connect to your account.